Funding for this research was provided by:
China National Major Project for New Drug Innovation (2017ZX09304015)
Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (2016-I2M-1-001)
Received: 12 November 2020
Accepted: 1 January 2021
First Online: 12 January 2021
Ethics approval and consent to participate
: The study was done in accordance with the Declaration of Helsinki and ICH guidelines for Good Clinical Practice. The protocol, protocol amendments, and patient informed consent were reviewed and approved by the relevant independent ethics committee at each participating study site prior to implementation. Written informed consent was obtained from all patients prior to enrolment.
: Not applicable.
: FX and QW are employees of Genor Biopharma Co., Ltd., China. The other authors declared no competing interests.